Abstract 10742: Implication of the Importins KPNA2 and KPNB1 in Pulmonary Arterial Hypertension
Sarah‐Eve Lemay(SNC-Lavalin (Canada)), François Potus(Queen's University), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Charlotte Romanet(Canadian Heart Research Centre), Mark Orcholski, Olivier Boucherat, Roxane Paulin, Charifa Awada, Victoria Toro(Canadian Heart Research Centre), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 1
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
|Science Translational Medicine|2024|33